Quality Control Niche MMQCI specializes in designing, manufacturing, and marketing quality control products for clinical laboratories to monitor the accuracy of molecular tests across inherited diseases, oncology, infectious diseases, and Next-Gen Sequencing panels, presenting a focused opportunity to upsell comprehensive QC solutions to molecular diagnostics labs.

Custom cGMP Capacity With a cGMP facility and openness to custom orders for in vitro diagnostic manufacturers, there is a clear path to engage potential clients needing tailored QC materials, regulatory-compliant production, and scalable QC programs.

Recent Product Launch Launch of the Birlinn CoV2-Flu-RSV Control Panel M509 signals ongoing innovation in respiratory and viral QC controls, offering a tangible entry point for sales conversations around newly required panels, expanded test menus, and compatibility with current lab workflows.

Mid‑Market Growth With 51-200 employees and annual revenue in the 10–25 million range, MMQCI sits between niche specialized suppliers and larger players, presenting a target profile for labs seeking high-quality, responsive QC partners with flexible pricing and service models.

Strategic Partnerships Existing expertise in emergent nucleic acid technologies and a history of custom orders create opportunities to partner with labs and manufacturers expanding into new assays or sequencing panels, offering co-development, validation support, and joint go‑to‑market initiatives.